Currently, there are 118.60M common shares owned by the public and among those 115.62M shares have been available to trade.
The company’s stock has a 5-day price change of -22.88% and 52.01% over the past three months. CLS shares are trading -5.35% year to date (YTD), with the 12-month market performance up to 184.93% higher. It has a 12-month low price of $30.84 and touched a high of $131.23 over the same period. CLS has an average intraday trading volume of 2.33 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -16.04%, -8.44%, and 35.89% respectively.
Institutional ownership of Celestica, Inc (NYSE: CLS) shares accounts for 76.00% of the company’s 118.60M shares outstanding.
It has a market capitalization of $10.17B and a beta (3y monthly) value of 2.29. The stock’s trailing 12-month PE ratio is 27.62, while the earnings-per-share (ttm) stands at $3.16. Price movements for the stock have been influenced by the stock’s volatility, which stands at 8.96% over the week and 5.33% over the month.
Earnings per share for the fiscal year are expected to increase by 59.16%, and 15.74% over the next financial year.
Looking at the support for the CLS, a number of firms have released research notes about the stock. UBS stated their Neutral rating for the stock in a research note on November 22, 2024, with the firm’s price target at $95. Barclays coverage for the Celestica, Inc (CLS) stock in a research note released on November 05, 2024 offered a Overweight rating with a price target of $91. Stifel was of a view on September 09, 2024 that the stock is Buy, while Fox Advisors gave the stock Overweight rating on May 15, 2024, issuing a price target of $60. CIBC on their part issued Neutral rating on April 26, 2024.
